Biotech

All Articles

Galapagos pauses CAR-T cell therapy hearing over Parkinsonism instance

.Galapagos has stopped registration in a trial of a BCMA-directed CAR-T tissue therapy, pushing the ...

James Wilson leaving Penn to introduce two new biotechs

.After more than 30 years, gene treatment trailblazer James Wilson M.D., Ph.D., is leaving behind th...

3 biotechs attempt to beat the summer months warm through shedding workers

.As biotechs attempt to turn a fresh webpage in August, at the very least three firms have actually ...

venBio elevates $528M for 5th life scientific researches VC fund

.Veteran financial backing organization venBio has actually raised yet another half a billion dollar...

Otsuka pays out $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Drug has picked up Boston-based Jnana Rehabs for $800 thousand so the Eastern biotech may re...

FibroGen lays off 75% people team as resource fails 2 more tests

.FibroGen is actually drastically restructuring its organization, laying off 75% of its U.S. team as...

Tracon wane weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually made a decision to unwind procedures weeks after an injectable ...

Ideaya bags option on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on stopped working epilepsy medicine, boasts FDA run

.Our team presently recognize that Takeda is wishing to discover a course to the FDA for epilepsy me...

VBI Vaccines declare bankruptcy, finds property purchase

.Immunology biotech VBI Injections is drifting hazardously near the point of no return, along with s...